التفاصيل البيبلوغرافية
العنوان: |
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis. |
المؤلفون: |
Samadder, N. Jewel, Foster, Nathan, McMurray, Ryan P., Burke, Carol A., Stoffel, Elena, Kanth, Priyanka, Das, Rohit, Correa, Marcia Cruz, Vilar, E., Mankaney, Gautam, Buttar, Navtej, Thirumurthi, Selvi, Turgeon, Danielle K., Sossenheimer, Michael, Westover, Michelle, Richmond, Ellen, Umar, Asad, Della'Zanna, Gary, Rodriguez, Luz M., Szabo, Eva |
المصدر: |
Gut; Feb2023, Vol. 72 Issue 2, p256-263, 8p |
مصطلحات موضوعية: |
ADENOMATOUS polyposis coli, ADENOMATOUS polyps, ERLOTINIB, POLYPS |
قاعدة البيانات: |
Complementary Index |